HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.

Abstract
The Ets-related gene (ERG) is an Ets-transcription factor required for normal blood stem cell development. ERG expression is down-regulated during early T-lymphopoiesis but maintained in T-acute lymphoblastic leukemia (T-ALL), where it is recognized as an independent risk factor for adverse outcome. However, it is unclear whether ERG is directly involved in the pathogenesis of T-ALL and how its expression is regulated. Here we demonstrate that transgenic expression of ERG causes T-ALL in mice and that its knockdown reduces the proliferation of human MOLT4 T-ALL cells. We further demonstrate that ERG expression in primary human T-ALL cells is mediated by the binding of other T-cell oncogenes SCL/TAL1, LMO2, and LYL1 in concert with ERG, FLI1, and GATA3 to the ERG +85 enhancer. This enhancer is not active in normal T cells but in transgenic mice targets expression to fetal liver c-kit(+) cells, adult bone marrow stem/progenitors and early CD4(-)CD8(-) double-negative thymic progenitors. Taken together, these data illustrate that ERG promotes T-ALL and that failure to extinguish activity of stem cell enhancers associated with regulatory transcription factors such as ERG can contribute to the development of leukemia.
AuthorsJulie A I Thoms, Yehudit Birger, Sam Foster, Kathy Knezevic, Yael Kirschenbaum, Vashe Chandrakanthan, Georg Jonquieres, Dominik Spensberger, Jason W Wong, S Helen Oram, Sarah J Kinston, Yoram Groner, Richard Lock, Karen L MacKenzie, Berthold Göttgens, Shai Izraeli, John E Pimanda
JournalBlood (Blood) Vol. 117 Issue 26 Pg. 7079-89 (Jun 30 2011) ISSN: 1528-0020 [Electronic] United States
PMID21536859 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Basic Helix-Loop-Helix Transcription Factors
  • DNA-Binding Proteins
  • ERG protein, human
  • LIM Domain Proteins
  • LMO2 protein, human
  • LYL1 protein, human
  • Metalloproteins
  • Neoplasm Proteins
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-vav
  • RNA, Messenger
  • T-Cell Acute Lymphocytic Leukemia Protein 1
  • Trans-Activators
  • Transcriptional Regulator ERG
  • TAL1 protein, human
Topics
  • Adaptor Proteins, Signal Transducing
  • Animals
  • Base Sequence
  • Basic Helix-Loop-Helix Transcription Factors (metabolism)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cells, Cultured
  • DNA-Binding Proteins (metabolism)
  • Gene Expression Regulation, Leukemic
  • Gene Knockdown Techniques
  • Humans
  • LIM Domain Proteins
  • Metalloproteins (metabolism)
  • Mice
  • Mice, Transgenic
  • Molecular Sequence Data
  • Neoplasm Proteins (metabolism)
  • Neoplasm Transplantation
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (genetics, metabolism, pathology)
  • Promoter Regions, Genetic
  • Proto-Oncogene Proteins (metabolism)
  • Proto-Oncogene Proteins c-vav (genetics, metabolism)
  • RNA, Messenger (metabolism)
  • Sequence Alignment
  • Survival Analysis
  • T-Cell Acute Lymphocytic Leukemia Protein 1
  • T-Lymphocytes (metabolism, pathology)
  • Trans-Activators (antagonists & inhibitors, chemistry, genetics, metabolism)
  • Transcriptional Regulator ERG

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: